PubRank

Shunichi Takahata

Author PubWeight™ 45.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 2009 2.41
2 Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 2010 1.14
3 An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery 2011 1.02
4 High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma. Oncol Rep 2013 0.99
5 Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 2013 0.98
6 The prevalence of circumportal pancreas as shown by multidetector-row computed tomography. Insights Imaging 2011 0.98
7 Significance of telemedicine for video image transmission of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography procedures. J Hepatobiliary Pancreat Sci 2011 0.97
8 Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 2010 0.96
9 MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma. JOP 2010 0.96
10 Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 2010 0.96
11 Repeated Pancreatectomy for Recurrent Pancreatic Carcinoma after Pylorus-Preserving Pancreatoduodenectomy: Report of Two Patients. Case Rep Gastroenterol 2010 0.94
12 Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg 2011 0.93
13 Differential diagnosis of groove pancreatic carcinomas vs. groove pancreatitis: usefulness of the portal venous phase. Eur J Radiol 2009 0.91
14 Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production. J Gastroenterol 2012 0.91
15 Lateral approach for laparoscopic splenic vessel-preserving distal pancreatectomy. Surgery 2011 0.90
16 Comparative study of laparoscopic and open distal pancreatectomy. J Laparoendosc Adv Surg Tech A 2010 0.89
17 Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg 2014 0.88
18 Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition. PLoS One 2012 0.88
19 Multifocal pancreatic ductal adenocarcinomas concomitant with intraductal papillary mucinous neoplasms of the pancreas detected by intraoperative pancreatic juice cytology. A case report. JOP 2010 0.88
20 Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol 2011 0.87
21 Prolonged peri-firing compression with a linear stapler prevents pancreatic fistula in laparoscopic distal pancreatectomy. Surg Endosc 2010 0.84
22 Role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma. Surg Today 2014 0.84
23 Targeting the hedgehog signaling pathway with interacting peptides to Patched-1. J Gastroenterol 2011 0.84
24 Is cholecystectomy necessary after endoscopic treatment of bile duct stones in patients older than 80 years of age? J Gastroenterol 2011 0.83
25 Adenocarcinoma involving the whole pancreas with multiple pancreatic masses. Intern Med 2010 0.82
26 Peroral pancreatoscopy using the SpyGlass system for the assessment of intraductal papillary mucinous neoplasm of the pancreas. J Hepatobiliary Pancreat Sci 2013 0.82
27 Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal papillary mucinous neoplasm: a case report. JOP 2013 0.82
28 Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci 2013 0.82
29 Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Pancreas 2015 0.81
30 Midkine mRNA is overexpressed in pancreatic cancer. Dig Dis Sci 2008 0.81
31 Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens. Cancer Sci 2008 0.81
32 Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2012 0.81
33 MAL2 expression predicts distant metastasis and short survival in pancreatic cancer. Surgery 2013 0.80
34 Factors in intraductal papillary mucinous neoplasms of the pancreas predictive of lymph node metastasis. Pancreatology 2011 0.80
35 Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life. World J Surg 2015 0.80
36 Short- and long-term results of the Frey procedure for chronic pancreatitis. J Hepatobiliary Pancreat Sci 2014 0.80
37 Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm. Ann Surg 2016 0.80
38 CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells. PLoS One 2012 0.79
39 Migratory activity of CD105+ pancreatic cancer cells is strongly enhanced by pancreatic stellate cells. Pancreas 2013 0.79
40 Different incretin responses after pancreatoduodenectomy and distal pancreatectomy. Pancreas 2012 0.79
41 Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas. J Hepatobiliary Pancreat Sci 2013 0.78
42 Biliary sphincter motility after neural isolation of the pancreatoduodenal region in conscious dogs. Surgery 2002 0.78
43 Profiling of autoantibodies in sera of pancreatic cancer patients. Ann Surg Oncol 2014 0.78
44 Manometric evidence of earlier recovery of fasting gastric motility after antecolic duodenojejunostomy than after retrocolic duodenojejunostomy following PPPD. Hepatogastroenterology 2012 0.78
45 Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012. World J Surg 2014 0.78
46 Prevention of iatrogenic bile duct injuries in difficult laparoscopic cholecystectomies: is the naso-biliary drain the answer? J Hepatobiliary Pancreat Surg 2009 0.78
47 Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 2010 0.77
48 [Surgical treatment of gastroentero-pancreatic neuroendocrine tumor]. Gan To Kagaku Ryoho 2013 0.77
49 Prediction of Pancreatic Fistula by Preoperatively Assessable Factors; Retrospective Review of Unified Operations by Single Surgeon. Hepatogastroenterology 2014 0.77
50 Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Pancreas 2016 0.76
51 A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice. Pancreas 2013 0.76
52 Successful endoscopic unroofing for a pediatric choledochocele. J Pediatr Surg 2009 0.76
53 Intramural incision technique: do we know enough to continue? Gastrointest Endosc 2008 0.75
54 Gastric phase 3 motility after pylorus-preserving pancreatoduodenectomy. Ann Surg 2002 0.75
55 Laparoscopic surgery is applicable for larger mucinous cystic neoplasms of the pancreas. J Hepatobiliary Pancreat Sci 2013 0.75
56 [Pancreatic tumor: progress in diagnosis and treatment. Topics: III. Pancreatic endocrine tumor; 2. Current status of the treatment of pancreatic neuroendocrine tumors]. Nihon Naika Gakkai Zasshi 2012 0.75
57 [Risk factors for malignant and recurrent IPMNs]. Nihon Rinsho 2015 0.75
58 Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study. Pancreas 2015 0.75
59 Combination therapy of portal vein resection and adjuvant gemcitabine improved prognosis of advanced pancreatic cancer. Hepatogastroenterology 2013 0.75
60 Extensive distal pancreatectomy for pancreatic tumor. Anticancer Res 2013 0.75
61 [Postoperative surveillance after resection of IPMN]. Nihon Rinsho 2015 0.75
62 Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved? Indian J Gastroenterol 2013 0.75
63 [A case of gastrointestinal stromal tumor of the jejunum successfully treated by preoperative induction chemotherapy with imatinib mesylate administered through jejunostomy and subsequent surgical resection]. Gan To Kagaku Ryoho 2014 0.75
64 A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology 2011 0.75
65 [Present status and perspective in clinical research of pancreatic neuroendocrine tumor]. Nihon Rinsho 2011 0.75